Şahin and Türeci Honored for Vaccine Innovation
WASHINGTON, May 13, 2026 The Sabin Vaccine Institute honored renowned vaccine researchers Professor Uğur Şahin and Professor Özlem Türeci...
Pharma
Advertisement
Lupin Wins U.S. FDA Approval for Famotidine Injection
MUMBAI, India and NAPLES, Fla., May 13, 2026 Global pharmaceutical company Lupin Limited announced that it has received approval...
Lilly Partners With UNICEF to Expand Pediatric Healthcare Access
NEW YORK and INDIANAPOLIS, May 14, 2026 Eli Lilly and Company and UNICEF USA announced a major global healthcare...
Atossa Advances (Z)-Endoxifen With FDA-Backed Strategy to Accelerate Breast Cancer Development Pathways
Seattle, WA — December 4, 2025 Atossa Therapeutics has outlined an accelerated FDA regulatory strategy to advance its investigational therapy,...
FDA Grants Orphan Drug Designation to J&D’s HCC Therapy, Accelerating New Options for Liver Cancer Treatment
Monmouth, NJ — December 4, 2025 J & D Pharmaceuticals LLC has received U.S. FDA Orphan Drug Designation for its...
Advertisements
ANI Pharmaceuticals to Present at Piper Sandler Conference
PRINCETON, N.J., Nov. 25, 2025 — ANI Pharmaceuticals’ announcement of its participation in the upcoming Piper Sandler 37th Annual...
Lilly Invests $6.5 B to Build API Plant in Houston
Houston, Texas – September 23, 2025 — Eli Lilly and Company (NYSE: LLY) will invest $6.5 billion to build...
Merck’s CAPVAXIVE Shows Strong Immune Response in Children
RAHWAY, N.J. – September 11, 2025 – Merck (NYSE: MRK), known as MSD outside the United States and Canada,...
Lilly and Julianne Moore Team Up on “Brain Health Matters” Alzheimer’s Awareness Campaign
INDIANAPOLIS, Sept. 9, 2025, Eli Lilly and Company (NYSE: LLY) has launched a new global initiative, “Brain Health Matters,”...
Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) today announced that the U.S. Food and Drug Administration (FDA) has approved its risperidone...
Advertisement
